Renal Diseases a)IgA nephropathy, purpura nephritis b)lupus nephritis c)minimal change nephrotic syndrome, focal segmental glomerulosclerosis d)ANCA associated vasculitis and related diseases
Conditions
Interventions
None listed
Sponsors
Nagoya University Graduate School of Medicine, Nephrology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: the patients who have been enrolled in Nagoya-Kidney Disease Registry (N-KDR) and diagnosed renal diseases indicated below by renal biopsy a)IgA nephropathy, purpura nephritis b)lupus nephritis c)minimal change nephrotic syndrome, focal segmental glomerulosclerosis d)ANCA associated vasculitis and related diseases
Exclusion criteria
Exclusion criteria: the patients who refuse consent (consent withdrawal)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a. eGFR 30% reduction, end-stage renal disease (initiation of dialysis therapy and renal transplantation) or death b. complete remission (proteinuria <0.3g/gCr or 0.3g/day) | — |
Secondary
| Measure | Time frame |
|---|---|
| a. incomplete remission (proteinuria <1.0g/gCr or 1.0g/day) b. infectious hospitalization c. onset of diabetes mellitus d. cardiovascular event including myocardial infarction, angina pectoris, aortic dissection, aortic rupture and others e. stroke including cerebral hemorrhage, cerebral infarction, subarachnoid hemorrhage and others f. cancer | — |
Countries
Japan
Contacts
Public ContactSawako Kato
Nagoya University Graduate School of Medicine, Internal Medicine Nephrology
Outcome results
None listed